Get Involved
On the day

Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies

Posted:

Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.

Previous post
Back to list
Next post